FDA Allows Orphan Drug Status for Low-Dose Naltrexone…

Soin Therapeutics, a pharmaceutical company, based in Dayton, OH, was granted orphan drug status from the FDA for low dose naltrexone (LDN) to treat complex regional pain syndrome (CRPS).   Soin Therapeutics is currently developing…

Dr. Lisa Leit: An Executive Coach Who Combines…

The picture-perfect social media posts that are snapped during our best moments on vacations or at events and then put on Instagram and Facebook don’t tell the real story of how many people feel: 75%…